Journals / Journal of Clinical and Analytical Medicine / 2015 / Cilt: 6 - Sayı: 1

Histereskopik Submüköz Myom Rezeksiyonunun, Menstrual Dönemde Kullanılan Ped Sayısı Üzerine Etkisi

The Effects of Hysteroscopic Submucosal Myoma Resection on Number of Sanitary Pads

Pages
75–78
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In thepostoperative 6th month on the day of heaviest menstrual bleeding averagenumber of pads used dropped to 3.8 compared to 9.1 in the preoperativeperiod (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To research the effect of hysteroscopic resection of submucosal myoma(HRSM) on the amount of pads used during the menstrual period in a premenopausal patient with menometrorrhagia caused by submucosal fibroids.
📊
Key Findings & Data:Material and Method: A total of 27 women with submucosal fibroids wereincluded in this prospective study using the Pictorial Blood Assessment Chart(PBAC) to evaluate quantity of menorrhagia.
💡
Conclusion & Impact:In thepostoperative 6th month on the day of heaviest menstrual bleeding averagenumber of pads used dropped to 3.8 compared to 9.1 in the preoperativeperiod (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: To research the effect of hysteroscopic resection of submucosal myoma(HRSM) on the amount of pads used during the menstrual period in a premenopausal patient with menometrorrhagia caused by submucosal fibroids. Material and Method: A total of 27 women with submucosal fibroids wereincluded in this prospective study using the Pictorial Blood Assessment Chart(PBAC) to evaluate quantity of menorrhagia. Bleeding evaluation and numberof pads used by patients in the 6th month after HRSM were recorded. Results: The average age of patients included in the study was 41±5.1. Of 27patients 20 (74%) had one. 4 (14%) had two and 3 (12%) had three or moresubmucosal myomas. The diameter of removed fibroids were 17 (63%) lessthan 3 cm, 6 (22%) between 3 and 5 cm and 4 (15%) were above 5 cm. In thepostoperative 6th month on the day of heaviest menstrual bleeding averagenumber of pads used dropped to 3.8 compared to 9.1 in the preoperativeperiod (p

Özet

Amaç: Premenepozal dönemde submüköz myom nedeniyle menometrorajisi olan hastalarda, histereskopik submükoz myom rezeksiyonunun (HSMR),menstrual dönemde kullanılan ped sayısı üzerine etkisini araştırmak. Gereç veYöntem: Menoraji miktarları Pictorial Blood Assessment Chart (PBAC) yöntemi kullanılarak değerlendirilen ve submüköz myomu olan 27 kadın prospektifolarak çalışmaya alındı. Hastalara HSMR yapıldıktan sonra 6. Ayda kanamadeğerlerinin kullandıkları ped sayısı üzerine olan etkisi kaydedildi. Bulgular:Çalışmaya dâhil edilen hasta gurubunun yaş ortalaması 41± 5.1 idi. 27 hastanın 20sinde (%74) bir tane, 4ünde (%14) iki ve 3ünde (%12) üç veya dahafazla submükoz myom mevcuttu. Çıkarılan myomların 17si (%63) 3 cmnin altında, 6sı (%22) 3-5 cm arasında ve 4ü (%15) 3cmnin üzerinde çapa sahipti.Hastaların postoperatif 6. ayda menstruel kanamanın en yoğun olduğu günlerdeki ortalama ped sayıları preoperatif döneme göre 9.1den 3.8e düştüğü(p

🔖

Cite This Article

UYSAL, A., TANER, C. E., ÖNOĞLU, A. S., UYSAL, F., MUN, S. (2022). Histereskopik Submüköz Myom Rezeksiyonunun, Menstrual Dönemde Kullanılan Ped Sayısı Üzerine Etkisi. Journal of Clinical and Analytical Medicine, Cilt: 6 - Sayı: 1, 75–78. https://ajindex.com/articles/560999

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. NICE. CG44. Heavy Menstrual Bleeding. Clinical Guideline No
  2. National Collaborating Centre for Women’s and Children’s Health Commissioned by the Na- tional Institute for Health and Clinical Excellence. RCOG Press. NewYork; 2007
  3. ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin. Surgical alternatives to hysterectomy in the management of leiomyomas. Int J Gynaecol Obstet 2001;73(3):285-93
  4. Yang JH, Chen MJ, Chen CD, Chen CL, Ho HN, Yang YS. Yang Impact of submu- cous myoma on the severity of anemia. Fertil Steril 2011;95(5):1769-72
  5. Lefebvre G, Vilos G, Allaire C, Jeffrey J, Arneja J, Birch C, et al. (Clinical Practice Gynaecology Committee, Society for Obstetricians and Gynaecologists of Canada.) The management of uterine leiomyomas. J Obstet Gynaecol Can 2003;25(5):396-418
  6. Neuwirth RS, Amin HK. Excision of submucus fibroids with hysteroscopic control. Am J Obstet Gynecol 1976;126(1):95-9
  7. Lasmar RB, Xinmei Z, Indman PD, Celeste RK, Di Spiezio Sardo A. Feasibility of a new system of classification of submucous myomas: a multicenter study. Fertil Steril 2011;95(6):2073-7
  8. Öndiman PD. Hsteroscopic treatment of submucous myomas. Clin Obstet Gy- necol. 2006 Dec; 49(4);811-20.Rewiv
  9. Loffer FD. Hysteroscopic myomectomy in postmenopausal women. J Minim Önvasive Gynecol 2005;12(4):323-5
  10. Vercellini P, Zaina B, Yaylayan L, Pisacreta A, De Giorgi O, Crosignani PG. Hysteroscopic myomectomy: long-term effects on menstrual pattern and fertility. Obstetrics and Gynecology 1999;94(3):341–7. 10. van Dongen H, Emanuel MH, Smeets MJ, Trimbos B, Jansen FW. Follow-up after incomplete hysteroscopic removal of uterine fibroids. Acta Obstet Gynecol Scand 2006;85(12):1463-7
  11. Higham JM, O’Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990;97(8):734-9
  12. Metwally M, Cheong YC, Horne AW. Surgical treatment of fibroids for subfer- tility. Cochrane Database Syst Rev 2012;11:CD003857. doi: 10.1002/14651858. CD003857.pub3
  13. Brooks PG, Loffer FD, Serden SP. Resectoscopic removal of symptomatic intra- uterine lesions. J Reprod Med 1989;34(7):435-7
  14. Coddington CC, Grow DR, Ahmed MS, Toner JP, Cook E, Diamond MP. Gonad- otropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial. Fertil Steril 2009;91(5):1909-13. doi: 10.1016/j.fertnstert.2008.02.128 15. Campo S. Hysteroscopy req